U.S. flag

An official website of the United States government

NM_000539.3(RHO):c.45T>G (p.Asn15Lys) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 8, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001858663.3

Allele description

NM_000539.3(RHO):c.45T>G (p.Asn15Lys)

Gene:
RHO:rhodopsin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q22.1
Genomic location:
Preferred name:
NM_000539.3(RHO):c.45T>G (p.Asn15Lys)
HGVS:
  • NC_000003.12:g.129528778T>G
  • NG_009115.1:g.5140T>G
  • NM_000539.3:c.45T>GMANE SELECT
  • NP_000530.1:p.Asn15Lys
  • NC_000003.11:g.129247621T>G
Protein change:
N15K
Links:
dbSNP: rs1578278088
NCBI 1000 Genomes Browser:
rs1578278088
Molecular consequence:
  • NM_000539.3:c.45T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002180945Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Feb 8, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Autosomal dominant 'sector' retinitis pigmentosa due to a point mutation predicting an Asn-15-Ser substitution of rhodopsin.

Kranich H, Bartkowski S, Denton MJ, Krey S, Dickinson P, Duvigneau C, Gal A.

Hum Mol Genet. 1993 Jun;2(6):813-4. No abstract available.

PubMed [citation]
PMID:
8353500

Visual function in retinitis pigmentosa related to a codon 15 rhodopsin gene mutation.

Yoshii M, Murakami A, Akeo K, Fujiki K, Saga M, Mizukawa A, Itoh J, Okisaka S, Yanashima K, Hotta Y, Kanai A, Oguchi Y.

Ophthalmic Res. 1998;30(1):1-10.

PubMed [citation]
PMID:
9483582
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV002180945.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Asn15 amino acid residue in RHO. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8353500, 9483582, 31100078). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RHO protein function. ClinVar contains an entry for this variant (Variation ID: 802004). This missense change has been observed in individuals with autosomal dominant retinitis pigmentosa (PMID: 30538586; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 15 of the RHO protein (p.Asn15Lys).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024